Related Experiment Videos

EGFR as a predictor of relapse in myxopapillary ependymoma

Anupam Verma1, Holly Zhou, Steve Chin

  • 1Division of Pediatric Hematology/Oncology, Primary Children's Medical Center, Salt Lake City, Utah, USA.

Pediatric Blood & Cancer
|December 23, 2011
PubMed

Insights

Myxopapillary ependymoma (MPE) recurrence may be predicted by Epidermal Growth Factor Receptor (EGFR) expression. This biomarker was present in relapsed tumors but absent in nonrecurring ones, offering a new diagnostic avenue.

Area of Science:

  • Pediatric Neuro-oncology
  • Molecular Pathology
  • Ependymoma Research

Background:

  • Myxopapillary ependymoma (MPE) is a rare, WHO Grade I pediatric tumor.
  • MPE exhibits unpredictable behavior, with a significant risk of recurrence and dissemination.
  • Currently, no reliable molecular markers predict MPE recurrence risk.

Purpose of the Study:

  • To identify potential molecular biomarkers for predicting recurrence in pediatric Myxopapillary ependymoma.
  • To investigate the role of Epidermal Growth Factor Receptor (EGFR) expression in MPE behavior.

Main Methods:

  • Retrospective analysis of MPE tumor samples.
  • Assessment of Epidermal Growth Factor Receptor (EGFR) expression.
  • Correlation of EGFR expression with tumor recurrence and dissemination status.

Main Results:

  • Epidermal Growth Factor Receptor (EGFR) expression was detected in MPE tumors that relapsed.
  • EGFR expression was observed both at initial diagnosis and at the time of recurrence.
  • Nonrecurring MPE tumors showed no detectable EGFR expression.

Conclusions:

  • Epidermal Growth Factor Receptor (EGFR) expression may serve as a predictive biomarker for recurrence in pediatric Myxopapillary ependymoma.
  • EGFR status could aid in risk stratification and treatment planning for MPE patients.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...